Issue navigation
Volume 75, Issue 5, May 2020
Review
When antibiotics fail: a clinical and microbiological perspective on antibiotic tolerance and persistence of Staphylococcus aureus
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 5, May 2020, Pages 1071–1086, https://doi.org/10.1093/jac/dkz559
For debate
Antimicrobial stewardship failure: time for a new model
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 5, May 2020, Pages 1087–1090, https://doi.org/10.1093/jac/dkaa006
Systematic reviews
Study reporting quality among interventions to reduce antibiotic use is a barrier to evidence-informed policymaking on antimicrobial resistance: systematic review
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 5, May 2020, Pages 1091–1098, https://doi.org/10.1093/jac/dkz540
Can evidence-based decision support tools transform antibiotic management? A systematic review and meta-analyses
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 5, May 2020, Pages 1099–1111, https://doi.org/10.1093/jac/dkz543
Original research
A multicentre outbreak of ST45 MRSA containing deletions in the spa gene in New South Wales, Australia
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 5, May 2020, Pages 1112–1116, https://doi.org/10.1093/jac/dkz560
Evaluation of a fully automated bioinformatics tool to predict antibiotic resistance from MRSA genomes
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 5, May 2020, Pages 1117–1122, https://doi.org/10.1093/jac/dkz570
Discordances between molecular assays for rifampicin resistance in Mycobacterium tuberculosis: frequency, mechanisms and clinical impact
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 5, May 2020, Pages 1123–1129, https://doi.org/10.1093/jac/dkz564
Role of ppGpp-regulated efflux genes in Acinetobacter baumannii
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 5, May 2020, Pages 1130–1134, https://doi.org/10.1093/jac/dkaa014
Tigecycline efflux in Acinetobacter baumannii is mediated by TetA in synergy with RND-type efflux transporters
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 5, May 2020, Pages 1135–1139, https://doi.org/10.1093/jac/dkaa015
Characterization of a blaNDM-1-carrying IncHI5 plasmid from Enterobacter cloacae complex of food-producing animal origin
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 5, May 2020, Pages 1140–1145, https://doi.org/10.1093/jac/dkaa010
Expression of AraC/XylS stress response regulators in two distinct carbapenem-resistant Enterobacter cloacae ST89 biotypes
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 5, May 2020, Pages 1146–1150, https://doi.org/10.1093/jac/dkz569
OmpC regulation differs between ST131 and non-ST131 Escherichia coli clinical isolates and involves differential expression of the small RNA MicC
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 5, May 2020, Pages 1151–1158, https://doi.org/10.1093/jac/dkz566
A novel tigecycline resistance gene, tet(X6), on an SXT/R391 integrative and conjugative element in a Proteus genomospecies 6 isolate of retail meat origin
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 5, May 2020, Pages 1159–1164, https://doi.org/10.1093/jac/dkaa012
Longitudinal analysis of ESBL and carbapenemase carriage among Enterobacterales and Pseudomonas aeruginosa isolates collected in Europe as part of the International Network for Optimal Resistance Monitoring (INFORM) global surveillance programme, 2013–17
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 5, May 2020, Pages 1165–1173, https://doi.org/10.1093/jac/dkz571
Direct detection of intact Klebsiella pneumoniae carbapenemases produced by Enterobacterales using MALDI-TOF MS
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 5, May 2020, Pages 1174–1181, https://doi.org/10.1093/jac/dkaa007
Occurrence of cross-resistance and β-lactam seesaw effect in glycopeptide-, lipopeptide- and lipoglycopeptide-resistant MRSA correlates with membrane phosphatidylglycerol levels
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 5, May 2020, Pages 1182–1186, https://doi.org/10.1093/jac/dkz562
Impact of calmodulin inhibition by fluphenazine on susceptibility, biofilm formation and pathogenicity of caspofungin-resistant Candida glabrata
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 5, May 2020, Pages 1187–1193, https://doi.org/10.1093/jac/dkz565
MIC distributions for amphotericin B, fluconazole, itraconazole, voriconazole, flucytosine and anidulafungin and 35 uncommon pathogenic yeast species from the UK determined using the CLSI broth microdilution method
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 5, May 2020, Pages 1194–1205, https://doi.org/10.1093/jac/dkz568
Evaluation of penicillin G susceptibility testing methods for Staphylococcus lugdunensis
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 5, May 2020, Pages 1206–1211, https://doi.org/10.1093/jac/dkaa004
Repurposing drugs for treatment of Mycobacterium abscessus: a view to a kill
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 5, May 2020, Pages 1212–1217, https://doi.org/10.1093/jac/dkz523
Methionyl-tRNA synthetase inhibitor has potent in vivo activity in a novel Giardia lamblia luciferase murine infection model
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 5, May 2020, Pages 1218–1227, https://doi.org/10.1093/jac/dkz567
Lack of synergistic nephrotoxicity between vancomycin and piperacillin/tazobactam in a rat model and a confirmatory cellular model
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 5, May 2020, Pages 1228–1236, https://doi.org/10.1093/jac/dkz563
Pharmacokinetics of trimethoprim/sulfametrole in critically ill patients on continuous renal replacement therapy
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 5, May 2020, Pages 1237–1241, https://doi.org/10.1093/jac/dkz556
Plasma and intracellular pharmacokinetics of tenofovir disoproxil fumarate and emtricitabine in transgender women receiving feminizing hormone therapy
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 5, May 2020, Pages 1242–1249, https://doi.org/10.1093/jac/dkaa016
Effect of high-dose rifampicin on efavirenz pharmacokinetics: drug–drug interaction randomized trial
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 5, May 2020, Pages 1250–1258, https://doi.org/10.1093/jac/dkz557
Genetic influence of ABCG2, UGT1A1 and NR1I2 on dolutegravir plasma pharmacokinetics
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 5, May 2020, Pages 1259–1266, https://doi.org/10.1093/jac/dkz558
Do genetic variations in proximal tubule transporters influence tenofovir-induced renal dysfunction? An exploratory study in a Ghanaian population
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 5, May 2020, Pages 1267–1271, https://doi.org/10.1093/jac/dkaa008
Characterization of drug resistance and the defective HIV reservoir in virally suppressed vertically infected children in Mali
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 5, May 2020, Pages 1272–1279, https://doi.org/10.1093/jac/dkaa002
Prevalence of viral load suppression, predictors of virological failure and patterns of HIV drug resistance after 12 and 48 months on first-line antiretroviral therapy: a national cross-sectional survey in Uganda
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 5, May 2020, Pages 1280–1289, https://doi.org/10.1093/jac/dkz561
M184V/I does not impact the efficacy of abacavir/lamivudine/dolutegravir use as switch therapy in virologically suppressed patients
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 5, May 2020, Pages 1290–1293, https://doi.org/10.1093/jac/dkaa019
The algorithm used for the interpretation of doravirine transmitted drug resistance strongly influences clinical practice and guideline recommendations
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 5, May 2020, Pages 1294–1300, https://doi.org/10.1093/jac/dkaa009
HIV MDR is still a relevant issue despite its dramatic drop over the years
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 5, May 2020, Pages 1301–1310, https://doi.org/10.1093/jac/dkz554
Evaluating predictive markers for viral rebound and safety assessment in blood and lumbar fluid during HIV-1 treatment interruption
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 5, May 2020, Pages 1311–1320, https://doi.org/10.1093/jac/dkaa003
Efficacy of intermittent short cycles of integrase inhibitor-based maintenance ART in virologically suppressed HIV patients
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 5, May 2020, Pages 1321–1323, https://doi.org/10.1093/jac/dkz555
Rilpivirine in HIV-1-positive women initiating pregnancy: to switch or not to switch?
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 5, May 2020, Pages 1324–1331, https://doi.org/10.1093/jac/dkaa017
Rilpivirine plus cobicistat-boosted darunavir as a two-drug switch regimen in HIV-infected, virologically suppressed subjects on steady standard three-drug therapy: a randomized, controlled, non-inferiority trial (PROBE 2)
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 5, May 2020, Pages 1332–1337, https://doi.org/10.1093/jac/dkaa018
A behavioural approach to specifying interventions: what insights can be gained for the reporting and implementation of interventions to reduce antibiotic use in hospitals?
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 5, May 2020, Pages 1338–1346, https://doi.org/10.1093/jac/dkaa001
A nationwide parent survey of antibiotic use in Australian children
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 5, May 2020, Pages 1347–1351, https://doi.org/10.1093/jac/dkz448
Research letters
A new intrinsic aminoglycoside 6′-N-acetyltransferase subclass, AAC(6′)-III, in Burkholderia pseudomallei, Burkholderia mallei and Burkholderia oklahomensis
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 5, May 2020, Pages 1352–1353, https://doi.org/10.1093/jac/dkaa011
Pharmacokinetic profile of dolutegravir after transjugular intrahepatic portosystemic shunt placement
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 5, May 2020, Pages 1354–1356, https://doi.org/10.1093/jac/dkz572
Acute inflammatory demyelinating polyneuropathy following interruption of antiretroviral treatment and HIV rebound
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 5, May 2020, Pages 1356–1357, https://doi.org/10.1093/jac/dkz573
Letters to the Editor
Comment on: Emergence of plasmid-mediated oxazolidinone resistance gene poxtA from CC17 Enterococcus faecium of pig origin
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 5, May 2020, Pages 1358–1359, https://doi.org/10.1093/jac/dkz432
Emergence of plasmid-mediated oxazolidinone resistance gene poxtA from CC17 Enterococcus faecium of pig origin—authors’ response
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 5, May 2020, Pages 1359–1361, https://doi.org/10.1093/jac/dkaa054
Erratum
Erratum to: Emergence of plasmid-mediated oxazolidinone resistance gene poxtA from CC17 Enterococcus faecium of pig origin
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 5, May 2020, Page 1362, https://doi.org/10.1093/jac/dkaa055
